Skip to content

Sanofi reported shopping its contract manufacturing business, worth ~$1B

April 9, 2017

Banks are preparing debt packages of up to €500m to back a potential sale of French drug maker Sanofi’s European contract manufacturer business Cepia, banking sources said on Thursday.

Cepia is a division of Sanofi, dealing with what Sanofi calls “third party activities” such as supply and production and is hoped to fetch up to €1bn, banking sources said.

Information packages have gone out to potential bidders as the sale process kicks off and the business is expected to generate interest from a number of private equity and strategic bidders.


From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: